Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DBV Technologies | Paris | Healthcare | Pharmaceuticals | 27.4% | EUR 84.09M | -0.8x | -1.47 | EUR 0.81 | -7.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gaztransport et Technigaz SA | Paris | Energy | Oil & Gas Related Equipment and Services | 10.8% | EUR 5.26B | 18.2x | 0.19 | EUR 141.70 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.6% Upside | Upgrade to Pro+ | |
IDI | Paris | Financial | Investment Banking & Investment Services | 4.4% | EUR 487.80M | -407.1x | EUR 68.40 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.3% Upside | Upgrade to Pro+ | ||
Courtois | Paris | Real Estate | Real Estate Operations | -7.7% | EUR 8.76M | -30.6x | 1.12 | EUR 121 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | -22% | EUR 385.09M | -1.9x | -1.31 | EUR 6.10 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | -26.5% | EUR 147.86M | 3.1x | 0.01 | EUR 6.75 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | -32.8% | EUR 137M | -3.7x | -0.08 | EUR 2.88 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | -36.5% | EUR 164.56M | 7.4x | 0.05 | EUR 3.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |